Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 3.35% is 41% above its 5-year average of 2.38%, near the high end of its 5-year range (-0.57%–4.76%).
As of the fiscal period ended Wednesday, December 31, 2025. 7.97% below its 12-month average of 3.64%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
3.35%
RETURN ON ASSETS (ROA) AVG TTM
3.64%
RETURN ON ASSETS (ROA) AVG 3Y
3.29%
RETURN ON ASSETS (ROA) AVG 5Y
2.38%
RETURN ON ASSETS (ROA) AVG 10Y
2.36%
RETURN ON ASSETS (ROA) AVG 15Y
4.13%
RETURN ON ASSETS (ROA) AVG 20Y
5.98%
CURRENT VS TTM AVG
-7.97%
CURRENT VS 3Y AVG
+1.98%
CURRENT VS 5Y AVG
+40.76%
CURRENT VS 10Y AVG
+41.95%
CURRENT VS 15Y AVG
-18.97%
CURRENT VS 20Y AVG
-43.95%
SECTOR MEDIAN · HEALTHCARE
4.97%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-32.60%
vs the sector median at left
Zimmer Biomet Holdings, Inc.
Market Cap
$18.37B
Return on Assets (ROA)
3.35%
TTM Avg
3.64%
3Y Avg
3.29%
5Y Avg
2.38%
Market Cap
$16.97B
Return on Assets (ROA)
5.92%
TTM Avg
7.45%
3Y Avg
8.56%
5Y Avg
11.79%
Market Cap
$20.33B
Return on Assets (ROA)
-0.80%
TTM Avg
-5.49%
3Y Avg
-1.68%
5Y Avg
-1.68%
Market Cap
$15.90B
Return on Assets (ROA)
23.89%
TTM Avg
21.05%
3Y Avg
19.32%
5Y Avg
16.45%
Market Cap
$15.12B
Return on Assets (ROA)
10.16%
TTM Avg
7.10%
3Y Avg
8.43%
5Y Avg
7.35%
Market Cap
$21.96B
Return on Assets (ROA)
19.17%
TTM Avg
16.59%
3Y Avg
14.73%
5Y Avg
13.22%
Market Cap
$14.40B
Return on Assets (ROA)
1.89%
TTM Avg
3.10%
3Y Avg
3.02%
5Y Avg
7.71%
Market Cap
$14.35B
Return on Assets (ROA)
-5.37%
TTM Avg
-3.64%
3Y Avg
-1.62%
5Y Avg
0.47%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Zimmer Biomet Holdings, Inc. (ZBH) | $18.37B | 3.35% | 3.64% | 3.29% | 2.38% |
| Hologic, Inc. (HOLX)vs › | $16.97B | 5.92% | 7.45% | 8.56% | 11.79% |
| Viatris Inc. (VTRS)vs › | $20.33B | -0.80% | -5.49% | -1.68% | -1.68% |
| Medpace Holdings, Inc. (MEDP)vs › | $15.90B | 23.89% | 21.05% | 19.32% | 16.45% |
| Solventum Corporation (SOLV)vs › | $15.12B | 10.16% | 7.10% | 8.43% | 7.35% |
| United Therapeutics Corporation (UTHR)vs › | $21.96B | 19.17% | 16.59% | 14.73% | 13.22% |
| DaVita Inc. (DVA)vs › | $14.78B | 4.47% | 4.84% | 4.27% | 4.56% |
| The Cooper Companies, Inc. (COO)vs › | $14.40B | 1.89% | 3.10% | 3.02% | 7.71% |
| Baxter International Inc. (BAX)vs › | $14.35B | -5.37% | -3.64% | -1.62% | 0.47% |
| Moderna, Inc. (MRNA)vs › | $22.44B | -28.75% | -24.02% | -10.32% | -0.33% |
ROA
3.4%
ROE
6.0%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 3.05% |
| 2024-12-31 | 4.23% |
| 2023-12-31 | 4.76% |
| 2022-12-31 | 1.10% |
| 2021-12-31 | 1.71% |
| 2020-12-31 | -0.57% |
| 2019-12-31 | 4.59% |
| 2018-12-31 | -1.57% |
| 2017-12-31 | 6.97% |
| 2016-12-31 | 1.15% |
| 2015-12-31 | 0.54% |
| 2014-12-31 | 7.48% |
| 2013-12-31 | 7.94% |
| 2012-12-31 | 8.38% |
| 2011-12-31 | 8.93% |
| 2010-12-31 | 7.46% |
| 2009-12-31 | 9.21% |
| 2008-12-31 | 11.72% |
| 2007-12-31 | 11.66% |
| 2006-12-31 | 13.97% |
| 2005-12-31 | 12.80% |
| 2004-12-31 | 9.51% |
| 2003-12-31 | 6.72% |
| 2002-12-31 | 30.02% |
| 2001-12-31 | 20.11% |
| 2000-12-31 | 29.46% |
| 1999-12-31 | 24.75% |
| 1998-12-31 | 0.00% |
